BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,006,000 | +3.4% | 19,884 | -0.3% | 0.46% | +7.8% |
| Q2 2022 | $2,907,000 | +16.5% | 19,949 | -5.2% | 0.42% | +52.7% |
| Q1 2022 | $2,495,000 | -45.8% | 21,044 | -37.0% | 0.28% | -28.8% |
| Q4 2021 | $4,602,000 | -2.5% | 33,395 | -1.7% | 0.39% | -6.3% |
| Q3 2021 | $4,718,000 | +38.0% | 33,965 | -3.6% | 0.42% | +38.8% |
| Q2 2021 | $3,420,000 | +32.4% | 35,228 | -6.8% | 0.30% | +24.6% |
| Q1 2021 | $2,583,000 | -21.2% | 37,790 | -1.3% | 0.24% | -17.0% |
| Q4 2020 | $3,280,000 | +7.0% | 38,270 | -18.8% | 0.29% | +20.9% |
| Q3 2020 | $3,065,000 | – | 47,141 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |